![](https://medcitynews.com/wp-content/uploads/sites/7/2016/10/GettyImages-482900853.jpg)
China’s Alphamab raises $100M in Series A financing from US, Asian investors
The Suzhou-based firm plans to use the money to advance its therapies, currently in clinical development in China and Australia.
The Suzhou-based firm plans to use the money to advance its therapies, currently in clinical development in China and Australia.